Princess Margaret Cancer Centre Research
@PMResearch_UHN
Followers
3K
Following
4K
Media
300
Statuses
2K
Research arm of @pmcancercentre—the largest integrated #cancer research, teaching and treatment centre in Canada. @UHN
Toronto, Ontario
Joined April 2019
🌟“Surprise is always the strongest signal that you found something new.”. Research from @GairdnerAwards awardee @decarvalho_lab is unlocking powerful new tools impacting cancer clinical care, from interception, detection to therapy design and monitoring.
2
8
23
Dr. Cheryl Arrowsmith received the Robert L. Noble Prize, for her work on understanding epigenetic protein interactions, creating new chemical probes and identifying vulnerabilities in cancer.
0
0
0
Dr. John Dick received The Lifetime Contribution Prize for his accomplishments ranging from discovering the cells that give rise to leukemia to developing new cancer treatments and finding ways to measure their success.
1
0
0
🎉Congratulations to our Senior Scientists Dr. Cheryl Arrowsmith and Dr. John Dick for receiving the Awards for Excellence in Cancer Research from Canadian Cancer Society! . @pmcancercentre @UHN @UHN_Research .
1
2
8
RT @UHN_Research: Last week, three @UHN researchers were named @CAHS_ACSS Fellows. This prestigious honour recognizes excellence in academi….
0
1
0
Active surveillance may be a safe choice over immediate surgery for older patients with small, low-risk thyroid cancer—only 24% needed surgery after 6 years, discovered in a collaborative study among Toronto hospitals, including @pmcancercentre @UHN:.
0
2
9
RT @UHN_Research: Congratulations to Dr. @RebeccaKSWong, Clinician Investigator @PMResearch_UHN, on being named a Fellow of the American So….
0
3
0
Congratulations to our clinicians Dr. Laura Dawson and Dr. Natasha Leighl for being elected to the Canadian Academy of Health Sciences as 2025 New Fellows🎉. @pmcancercentre @UHN_Research @UHN @thePMCF
Forty-seven new Fellows elected to the Canadian Academy of Health Sciences. View the full list of 2025 new Fellows here:
1
10
33
RT @CAHS_ACSS: Élection de 47 nouveaux membres à l’Académie canadienne des sciences de la santé. Consultez la liste complète des nouveaux….
0
1
0
RT @UHN_Research: @UHN @PMResearch_UHN @KITE_UHN @ganglabstyle The identification of a unique gamma delta T-cell receptor offers a promisin….
0
2
0
RT @gzheng74: Congrats to Michael Valic @ganglabstyle for a flawless PhD defense, who devoted 11 years (MS-RA-PhD) @PMResearch_UHN in makin….
0
3
0
Researchers developed a new molecule that binds to DCAF1, a protein linked to cancer growth and viral infection, opening new doors for cancer and HIV treatments. Developed by our Affiliate Scientist Dr. Levon Halabelian with @thesgconline & @OICR_news.
0
1
4
RT @UHN_Research: Read about the latest findings from Canada’s largest #research hospital in @UHN’s Research Spotlight newsletter:. ▶️#Leuk….
0
7
0
🎉Congratulations to our Head of Division of Medical Oncology and Hematology, and Clinician Investigator Dr. Natasha Leighl for receiving the ESMO Women for Oncology Award! @pmcancercentre @UHN @UHN_Research.
ESMO has announced the recipients of the 2025 ESMO Society Awards in recognition of their significant contributions to advancing the field of #oncology and supporting fellow professionals in their careers. 🔗
1
4
25
RT @UHN_Research: Hear from 2025 Gairdner Momentum Award winner Dr. Daniel De Carvalho (@decarvalho_lab) @PMResearch_UHN on October 23 at @….
uhnresearch.ca
Dr. Daniel De Carvalho wins 2025 Gairdner Momentum Award for advancing cancer detection.
0
6
0
🔬 New study found, in some head and neck cancers, losing one copy of the KEAP1 gene boosts NRF2 protein activity, which helps tumours become resistant to radiotherapy. Led by our Senior Scientist @DKirschMDPhD. Published in @CCR_AACR:
0
6
12
RT @GarvanInstitute: Huge thank you to Princess Margaret Cancer Centre for hosting Garvan at the Allan Slaight Breakthrough Forum. Grateful….
0
2
0
🇨🇦🇦🇺Thank you to @GarvanInstitute for joining us at the Allan Slaight Breakthrough Forum! Scientists were brought together to tackle tumour complexity for translational impact. Together, we’re accelerating the path toward more precise and effective cancer care.
1
3
6
RT @kyla_kumar: Celebrated the final edits ✍️ and next chapter 📚 of our dear Team @UHN colleague and friend Dan Girard as he embarks on ret….
0
1
0
The team's innovative work with Porphysomes has also recently received Health Canada’s approval and institutional approval to begin 1st-in-human clinical study led by Dr. Stephanie Lheureux. Check out the story here:
uhnresearch.ca
UHN-led innovation moves from lab to clinic with Health Canada approval for clinical trials.
0
0
0